novartispharma.com Novartispharma.com

   
Explore Stories | Novartis

Domain Summary

What is the traffic rank for Novartispharma.com?

• Novartispharma.com ranks #1,553,183 globally on HypeStat.

What percent of global Internet users visit Novartispharma.com?

2.9E-5% of global Internet users visit Novartispharma.com

How many people visit Novartispharma.com each day?

• Novartispharma.com receives approximately 1.4K visitors and 5,719 page impressions per day.

Which countries does Novartispharma.com receive most of its visitors from?

• Novartispharma.com is mostly visited by people located in United States.

How much Novartispharma.com can earn?

• Novartispharma.com should earn about $27.55/day from advertising revenue.

What is Novartispharma.com estimated value?

• Estimated value of Novartispharma.com is $25,493.89.

What IP addresses does Novartispharma.com resolve to?

• Novartispharma.com resolves to the IP addresses 45.60.13.232.

Where are Novartispharma.com servers located in?

• Novartispharma.com has servers located in Redwood City, California, 94065, United States.

novartispharma.com Profile

Title:Explore Stories | Novartis
Description:Explore stories about how Novartis innovation has impacted people worldwide.
Tags:

What technologies does novartispharma.com use?

These are the technologies used at novartispharma.com. novartispharma.com has a total of 11 technologies installed in 9 different categories.

novartispharma.com Traffic Analysis

Novartispharma.com is ranked #1,553,183 in the world. This website is viewed by an estimated 1.4K visitors daily, generating a total of 5.7K pageviews. This equates to about 43.3K monthly visitors.
Daily Visitors1.4K
Monthly Visits43.3K
Pages per Visit4.00
Visit duration n/a
Bounce Rate n/a
Is this your site?Verify your site's metrics.
Daily Unique Visitors:
1,430
Monthly Visits:
43,329
Pages per Visit:
4.00
Daily Pageviews:
5,719
Avg. visit duration:
n/a
Bounce rate:
n/a
Global Reach:
2.9E-5%
HypeRank:
1,553,183
*All traffic values are estimates only.

Visitors by country

Country
Users%
 
United States 94.9%

Where do visitors go on novartispharma.com?

 
Reach%Pageviews%PerUser
copay.novartispharma.com
91.45%97.33%3
OTHER
0%2.67%0
Last update was 2076 days ago
     
This can take up to 60 seconds. Please wait...

*HypeStat.com is not promoting or affiliated with novartispharma.com in any way. Only publicly available statistics data are displayed.

 

SEMrush is a complete on line advertising and marketing platform that gives a extensive variety of gear and functions to help companies and entrepreneurs in enhancing their on line visibility and optimizing their virtual advertising and marketing strategies.
SemRushSemRush
Domain:
  novartispharma.com
Rank:
(Rank based on keywords, cost and organic traffic)
  n/a
Organic Keywords:
(Number of keywords in top 20 Google SERP)
  0
Organic Traffic:
(Number of visitors coming from top 20 search results)
  0
Organic Cost:
((How much need to spend if get same number of visitors from Google Adwords)
  $0.00

Revenue report

Google.com would generate approximately $27.6 per day if the source of income were advertisements, which equates to an estimated monthly revenue of $826.5 and annual gross revenue of approximately $10.1K. Based on these figures, the site's net worth is estimated at around $25.5K.

How much would novartispharma.com make?

Daily Revenue:
$27.55
Monthly Revenue:
$826.50
Yearly Revenue:
$10,055.75
*All earnings values are estimates only.

Daily earning by country

 
CountryPageviewsEarning
 
United States 5,605$27.07

Loss of money due to Adblock?

Daily Revenue Loss:
$4.87
Monthly Revenue Loss:
$146.18
Yearly Revenue Loss:
$1,778.52
Daily Pageviews Blocked:
1,009
Monthly Pageviews Blocked:
30,265
Yearly Pageviews Blocked:
368,224

Daily revenue loss by country

 
CountryBlockedLost Money
 
United States 1,009$4.87

How much is novartispharma.com worth?

Website Value:
$25.5K

Ad Experience Report

Summary of the ad experience rating of a website for a specific platform.

Mobile summary

Root domain:
novartispharma.com
Ad filtering:
(Chrome is not filtering ads on your site.)
Off
Status:
(The status of the site that is reviewed for the Better Ads Standards.)
Not reviewed

Desktop summary

Root domain:
novartispharma.com
Ad filtering:
(Chrome is not filtering ads on your site.)
Off
Status:
(The status of the site that is reviewed for the Better Ads Standards.)
Not reviewed

Abusive Experience Report

Summary of the abusive experience rating of a website.
Root domain:
novartispharma.com
Enforcement:
(Chrome is not preventing your site from opening new windows or tabs.)
Off
Status:
(The status of the site reviewed for the abusive experiences.)
Not reviewed

Where is novartispharma.com hosted?

Novartispharma.com may be hosted in multiple data centers distributed in different locations around the world. This is probably just one of them.
Server IP:
45.60.13.232
ASN:
AS19551 
ISP:
Incapsula Inc 
Server Location:
Redwood City
California, CA
94065
United States, US
 

Other sites hosted on 45.60.13.232

Does novartispharma.com use compression?

Website compression is the process of reducing the size of website files, such as HTML, CSS, JavaScript, and image files, to improve website performance and load times. Compressing website files can significantly reduce the amount of data that needs to be transferred from the server to the user's browser, resulting in faster page load times and improved user experience. Files on novartispharma.com are reduced by %.
novartispharma.com does not use compression.
Original size: n/a
Compressed size: n/a
File reduced by: (%)

Google Safe Browsing

Google Safe Browsing is a service provided by Google that helps protect users from visiting websites that may contain malicious or harmful content, such as malware, phishing attempts, or deceptive software.
This site is not currently listed as suspicious

SSL Checker - SSL Certificate Verify

An SSL (Secure Sockets Layer) certificate is a digital certificate that establishes a secure encrypted connection between a web server and a user's web browser. It provides authentication and encryption, ensuring that data transmitted between the server and the browser remains private and protected. novartispharma.com supports HTTPS.
 novartispharma.com supports HTTPS
     
Verifying SSL Support. Please wait...
Common Name: retired.novartis.com
Organization:
Location:
Issuer: DigiCert SHA2 Secure Server CA
Valid from: May 29 00:00:00 2018 GMT
Valid until: May 18 12:00:00 2020 GMT
Authority:
Keysize:

Verify HTTP/2 Support

HTTP/2 (Hypertext Transfer Protocol version 2) is a major revision of the HTTP protocol, which is the foundation of data communication on the World Wide Web. It was developed as an improvement over the previous HTTP/1.1 version to enhance web performance and efficiency.
 novartispharma.com supports HTTP/2
     
Verifying HTTP/2.0 Support. Please wait...

Http Header

HTTP headers are extra portions of records despatched among a consumer (which include an internet browser) and a server at some stage in an HTTP request or response. They offer instructions, metadata, or manipulate parameters for the conversation among the consumer and server.
HTTP/1.1 301 Moved Permanently
Date: Wed, 03 Oct 2018 13:18:12 GMT
X-Frame-Options: SAMEORIGIN
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
Content-Type: text/html; charset=iso-8859-1
Location: https://www.novartispharmaceuticals.com/
Vary: Accept-Encoding
Content-Length: 248
Connection: close
Set-Cookie: TS01d52787=01f27bbbb1d2f0baacaca0552c47611a49359e46ef96b82b1b419d508130c4c45fcfa44c9ca2ce8a0acf977d0ed94e36a9a83a8589; Path=/
Set-Cookie: visid_incap_1358217=SKZPeq7QRWahMz6J34Co7pPBtFsAAAAAQUIPAAAAAADgyhj91De8vaKwGmIJPFk0; expires=Thu, 03 Oct 2019 10:49:25 GMT; path=/; Domain=.novartispharma.com
Set-Cookie: incap_ses_116_1358217=M5rmYvABvUM4zzimXDmcAZPBtFsAAAAADV0PskQqm5Ovjrs99NU9+A==; path=/; Domain=.novartispharma.com
Set-Cookie: ___utmvmKcuPvEwB=kXxBXfReSEp; path=/; Max-Age=900
Set-Cookie: ___utmvaKcuPvEwB=qsluLNl; path=/; Max-Age=900
Set-Cookie: ___utmvbKcuPvEwB=RZl
    XPSOQalG: utC; path=/; Max-Age=900
X-Iinfo: 10-49725691-49725693 NNNN CT(0 -1 0) RT(1538572691498 0) q(0 1 1 -1) r(2 2) U5
X-CDN: Incapsula
HTTP/1.1 301 Moved Permanently
Date: Wed, 03 Oct 2018 13:18:12 GMT
X-Frame-Options: SAMEORIGIN
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
Content-Type: text/html; charset=iso-8859-1
Location: https://www.novartis.com/stories
Vary: Accept-Encoding
Content-Length: 240
Connection: close
Set-Cookie: TS01d52787=01f27bbbb1b4ad7300079628483aa71b16f1d4062f56693c8c2cfdf10696709c751f4c38fbd5ef2ad9feae124fc6a5ac610b018cfa; Path=/
Set-Cookie: visid_incap_1358217=G7QUUurXSaGm5ho2MzynUZTBtFsAAAAAQUIPAAAAAAAM+8SoF3G9rW0IUN2/c98W; expires=Thu, 03 Oct 2019 10:49:32 GMT; path=/; Domain=.novartispharmaceuticals.com
Set-Cookie: incap_ses_116_1358217=oppAN/XJjyq00DimXDmcAZTBtFsAAAAADmgT5kFRguzP+DKUnSLBsg==; path=/; Domain=.novartispharmaceuticals.com
Set-Cookie: ___utmvmKcuPvEwB=IYXVGZPCReE; path=/; Max-Age=900
Set-Cookie: ___utmvaKcuPvEwB=PhrdrDD; path=/; Max-Age=900
Set-Cookie: ___utmvbKcuPvEwB=NZp
    XdqOZalF: Tto; path=/; Max-Age=900
X-Iinfo: 4-59143324-59143330 NNNN CT(0 0 0) RT(1538572691965 32) q(1 1 1 -1) r(2 2) U5
X-CDN: Incapsula
HTTP/1.1 200 OK
Date: Wed, 03 Oct 2018 13:18:13 GMT
Content-Type: text/html; charset=utf-8
Connection: close
Set-Cookie: __cfduid=d5af443c09e2cf53a59f1e5c99dec38dd1538572693; expires=Thu, 03-Oct-19 13:18:13 GMT; path=/; domain=.novartis.com; HttpOnly
X-Drupal-Cache: MISS
X-Content-Type-Options: nosniff
Content-Language: en
X-Frame-Options: SAMEORIGIN
X-UA-Compatible: IE=edge,chrome=1
Link: <https://www.novartis.com/stories>; rel="canonical",<https://www.novartis.com/stories>; rel="shortlink"
Cache-Control: public, max-age=86400
Last-Modified: Wed, 03 Oct 2018 13:05:50 GMT
Expires: Thu, 04 Oct 2018 13:18:13 GMT
Vary: Cookie,Accept-Encoding
X-Request-ID: 11830f4d9228ff6c8d1989b76889cc2d
X-AH-Environment: prod
X-Acquia-Application-UUID: bd001528-a8b3-27d4-29e1-34e36bb6ed42
CF-Cache-Status: HIT
Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
Server: cloudflare
CF-RAY: 463fb183aa725631-ORD

DNS Lookup

DNS entries (Domain Name System) are a critical component of the Internet infrastructure. They act as directories that translate human-readable domain names (such as example.com) to machine-readable IP addresses. DNS records are stored on DNS servers and help forward internet traffic efficiently.
Type Ip Target/Txt TTL
TXT 0ef12c72-9b73-4704-afec-ce2a5ff92d1e 3600
SOA 3600
Mname dns1.novartis.com
Rname hostmaster.novartis.com
Serial Number 2018092001
Refresh 28800
Retry 7200
Expire 604800
Minimum TTL 3600
A 45.60.11.232 3583
A 45.60.13.232 3583
NS mia03-1.digex.com 3583
NS dns1.novartis.com 3583
NS dns2.novartis.com 3583

Whois Lookup

Domain WHOIS is a public database that provides information about domain names, including registered owners, contact information, domain registrars, registration and expiration dates, name servers, and other relevant information. Domain registration for this website began on October 27, 1999 and will expire on June 10, 2024 if not renewed. This website is now assigned through the registrar . The WHOIS data for this website's domain was last updated on June 10, 2024.
Domain Created:
1999-10-27
Domain Age:
24 years 7 months 14 days
WhoIs:
 

whois lookup at whois.markmonitor.com...Domain Name: novartispharma.com
Registry Domain ID: 11748121_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2018-10-03T00:10:02-0700
Creation Date: 1999-10-27T00:00:00-0700
Registrar Registration Expiration Date: 2020-10-27T00:00:00-0700
Registrar: MarkMonitor, Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: email
Registrar Abuse Contact Phone: +1.2083895740
Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)
Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)
Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)
Domain Status: serverUpdateProhibited (https://www.icann.org/epp#serverUpdateProhibited)
Domain Status: serverTransferProhibited (https://www.icann.org/epp#serverTransferProhibited)
Domain Status: serverDeleteProhibited (https://www.icann.org/epp#serverDeleteProhibited)
Registrant Organization: Novartis AG
Registrant State/Province: -
Registrant Country: CH
Admin Organization: Novartis AG
Admin State/Province: -
Admin Country: CH
Tech Organization: Novartis AG
Tech State/Province: -
Tech Country: CH
Name Server: mia03.digex.com
Name Server: dns1.novartis.com
Name Server: dns2.novartis.com
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2018-10-03T06:18:26-0700 <<<

If certain contact information is not shown for a Registrant, Administrative,
or Technical contact, and you wish to send a message to these contacts, please
send your message to email and specify the domain name in
the subject line. We will forward that message to the underlying contact.

If you have a legitimate interest in viewing the non-public WHOIS details, send
your request and the reasons for your request to email
and specify the domain name in the subject line. We will review that request and
may ask for supporting documentation and explanation.

The Data in MarkMonitor.com's WHOIS database is provided by MarkMonitor.com for
information purposes, and to assist persons in obtaining information about or
related to a domain name registration record.  MarkMonitor.com does not guarantee
its accuracy.  By submitting a WHOIS query, you agree that you will use this Data
only for lawful purposes and that, under no circumstances will you use this Data to:
 (1) allow, enable, or otherwise support the transmission of mass unsolicited,
     commercial advertising or solicitations via e-mail (spam); or
 (2) enable high volume, automated, electronic processes that apply to
     MarkMonitor.com (or its systems).
MarkMonitor.com reserves the right to modify these terms at any time.
By submitting this query, you agree to abide by this policy.

MarkMonitor is the Global Leader in Online Brand Protection.

MarkMonitor Domain Management(TM)
MarkMonitor Brand Protection(TM)
MarkMonitor AntiPiracy(TM)
MarkMonitor AntiFraud(TM)
Professional and Managed Services

Visit MarkMonitor at http://www.markmonitor.com
Contact us at +1.8007459229
In Europe, at +44.02032062220

For more information on Whois status codes, please visit
 https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-enwhois lookup at whois.crsnic.net...Domain Name: NOVARTISPHARMA.COM
   Registry Domain ID: 11748121_DOMAIN_COM-VRSN
   Registrar WHOIS Server: whois.markmonitor.com
   Registrar URL: http://www.markmonitor.com
   Updated Date: 2018-09-25T09:03:19Z
   Creation Date: 1999-10-27T12:09:24Z
   Registry Expiry Date: 2020-10-27T12:09:24Z
   Registrar: MarkMonitor Inc.
   Registrar IANA ID: 292
   Registrar Abuse Contact Email: email
   Registrar Abuse Contact Phone: +1.2083895740
   Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
   Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
   Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
   Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited
   Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited
   Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited
   Name Server: DNS1.NOVARTIS.COM
   Name Server: DNS2.NOVARTIS.COM
   Name Server: MIA03.DIGEX.COM
   DNSSEC: unsigned
   URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-10-03T13:18:12Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar.  Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability.  VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.